520 / 1674
Proportion of patients eligible for APBI according to clinical
trial eligibility and consensus guidelines
(between 2010 and 2012)
APBI ASTRO
41.2%
APBI ABS
74.6%
APBI GEC ESTRO
74.6%
APBI GEC ESTRO trial
89.7%
APBI IMPORT LOW trial
75.0%
SEER analysis. Manyan BV et al, Am J Clin Oncol 2016